Editorial: mesalazine to prevent recurrent acute diverticulitis—the final nail in the coffin. Authors’ reply

por Kruis, W., Greinwald, R.
Publicado 2017

Successful Non-Invasive treatment of stricturing fibrosing colonopathy in an adult patient

por Terheggen, G, Dieninghoff, D, Rietschel, E, Drebber, U, Kruis, W, Leifeld, L
Publicado 2011

Bowel Preparation for Colonoscopy with Sodium Phosphate Solution versus Polyethylene Glycol-Based Lavage: A Multicenter Trial

por Schanz, S., Kruis, W., Mickisch, O., Küppers, B., Berg, P., Frick, B., Heiland, G., Hüppe, D., Schenck, B., Horstkotte, H., Winkler, A.
Publicado 2008

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

por Kruis, W, Kiudelis, G, Rácz, I, Gorelov, I A, Pokrotnieks, J, Horynski, M, Batovsky, M, Kykal, J, Boehm, S, Greinwald, R, Mueller, R
Publicado 2009

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

por Kruis, W., Kardalinos, V., Eisenbach, T., Lukas, M., Vich, T., Bunganic, I., Pokrotnieks, J., Derova, J., Kondrackiene, J., Safadi, R., Tuculanu, D., Tulassay, Z., Banai, J., Curtin, A., Dorofeyev, A. E., Zakko, S. F., Ferreira, N., Björck, S., Diez Alonso, M. M., Mäkelä, J., Talley, N. J., Dilger, K., Greinwald, R., Mohrbacher, R., Spiller, R.
Publicado 2017